Results 91 to 100 of about 1,574,000 (316)

Re‐Irradiation in Pediatric Diffuse Midline Glioma: A Multi‐Institutional Retrospective Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Children with recurrent diffuse midline gliomas (DMGs) have limited therapeutic options at recurrence. Re‐irradiation (RT2) may be used at progression, but with uncertainty about the benefit. Methods We conducted a multi‐institutional retrospective study of children aged < 18 with DMG treated at three centers (Toronto, Canada ...
Ajay Thomas Alex   +13 more
wiley   +1 more source

Kaplan—Meier survival analysis for patient survival. [PDF]

open access: yes, 2015
Kaplan—Meier analysis showed that patient survival in NDN group was significantly inferior to DN group (log rank 4.830, P = 0.028).
Zhaohui Ni (229588)   +10 more
core   +1 more source

Association Between Dinutuximab Beta Exposure and Post‐End‐of‐Treatment Survival in Neuroblastoma: A Weighted Patient‐Level Analysis of Three Clinical Studies

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objectives The association between exposure to dinutuximab beta (DB) and event‐free survival (EFS) or overall survival (OS) of neuroblastoma patients was assessed using data collected during three clinical trials (five cohorts). Methods A systematic review (March 2026) was conducted to identify relevant studies (prospective; registered DB ...
Przemysław Holko   +19 more
wiley   +1 more source

Unadjusted patient and/or graft survival analysis. [PDF]

open access: yes, 2013
(A) Patient-and-graft survival ( = overall graft survival) : patient deaths with a functioning graft are considered as a graft failure (log-rank test: p = 0.0127) (B) Death-censored graft survival: patient deaths with a functioning graft are censored ...
Michèle Kessler (302056)   +13 more
core   +1 more source

A Comprehensive Look at Focal Segmental Glomerulosclerosis Recurrence in Adult Transplant Patients: Findings from a Single Institution with Review of Literature

open access: yesIndian Journal of Transplantation
Background: Focal segmental glomerulosclerosis (FSGS) is a kidney disease with diverse causes, classified as primary, genetic, or secondary. There is a high recurrence rate of FSGS posttransplant and is associated with a significant risk of graft loss ...
Monika Yachha   +10 more
doaj   +1 more source

Long‐Term Outcomes of Patients With Relapsed/Refractory Neuroblastoma Treated on ANBL1221: A Report From the Children's Oncology Group

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Results of COG ANBL1221 changed treatment paradigms for patients with relapsed/refractory neuroblastoma. Chemoimmunotherapy with irinotecan/temozolomide/dinutuximab is now used as both bridge therapy following suboptimal response to induction and as treatment in first relapse.
Elizabeth Sokol   +6 more
wiley   +1 more source

Cumulative patient survival. [PDF]

open access: yes, 2016
Kaplan-Meier curve depicting cumulative patient survival censored for death. The solid line represents patients treated with HCO membranes, the dashed line represents patients treated by conventional HD filters. Cox regression analysis was performed with
Patrice M. Ambühl (3145374)   +4 more
core   +1 more source

Pre-Transplant Hypoalbuminemia Is Not Associated With Early Key Outcomes Among Simultaneous Pancreas and Kidney Transplant Recipients

open access: yesTransplant International
The role of pre-transplant hypoalbuminemia and its impact on post-transplant outcomes in patients undergoing simultaneous pancreas-kidney (SPK) transplantation remains unclear.
Ekaterina Fedorova   +10 more
doaj   +1 more source

Urgent-Start Peritoneal Dialysis as a Bridge to Definitive Chronic Renal Replacement Therapy: Short- and Long-Term Outcomes

open access: yesFrontiers in Physiology, 2019
Background: The peritoneal dialysis (PD) urgent-start pathway, without typical 2-week break-in period, was meant for late-referral patients able and prone to join PD-first program, with its main advantages such as: keeping the vascular system intact ...
Ewa Wojtaszek   +4 more
doaj   +1 more source

Measurable Residual Disease Monitoring During Treatment for Pediatric Acute Myeloid Leukemia in First Relapse

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Survival after relapse in pediatric acute myeloid leukemia (AML) remains poor, highlighting the critical importance of identifying prognostic factors to guide optimal relapse management. Methods We investigated the prognostic impact of multiparameter flow cytometry (MFC) measurable residual disease (MRD) in 188 patients with first ...
Camilla Poulsen   +21 more
wiley   +1 more source

Home - About - Disclaimer - Privacy